Stock Events

Stock Events

TAO Synergies 

$3.67
26
-$0.17-4.43% Thursday 20:00

Statistics

Day High
3.95
Day Low
3.62
52W High
11.98
52W Low
3.25
Volume
134,600
Avg. Volume
-
Mkt Cap
26.16M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7AugExpected
Q4 2024
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
-2.06
-1.23
-0.4
0.43
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-27.12MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TAOX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap29.53B
Biogen focuses on neurodegenerative diseases, directly competing with Synaptogenix's Alzheimer's and neurological disorder treatments.
Lilly(Eli) &
LLY
Mkt Cap1.01T
Eli Lilly has a strong pipeline in Alzheimer's disease treatments, making it a direct competitor in the neurodegenerative space.
Annovis Bio
ANVS
Mkt Cap75.72M
Annovis Bio is engaged in developing therapies for Alzheimer's and Parkinson's diseases, directly competing with Synaptogenix.
AC Immune SA
ACIU
Mkt Cap235.1M
AC Immune SA specializes in neurodegenerative diseases, including Alzheimer's, competing in the same therapeutic area as Synaptogenix.
Anavex Life Sciences
AVXL
Mkt Cap231.68M
Anavex Life Sciences Corp. focuses on developing drugs for Alzheimer's disease, directly competing in the same field.
Arbutus Biopharma
ABUS
Mkt Cap841.51M
Arbutus Biopharma Corporation, though primarily focused on antiviral drugs, has ventured into neurodegenerative diseases, positioning it as a potential competitor.

About

TAO Synergies Inc. operates as a biopharmaceutical company currently in the clinical development stage. It is dedicated to advancing a bryostatin-1 therapeutic platform, specifically designed to combat Alzheimer's and various other neurodegenerative and cognitive disorders. Beyond its drug development efforts, the firm is also diversifying its treasury strategy, with a new approach centered on the management of digital assets, primarily focusing on the acquisition and 'staking' of TAO cryptocurrency.
Show more...
CEO
Mr. Joshua N. Silverman
Employees
4
Country
United States
ISIN
US87167T3005

Listings

XNAS
US
TAOX
BOATS
BOATS
TAOX.BOATS

0 Comments

Share your thoughts

FAQ

What is TAO Synergies stock price today?▼
The current price of TAOX is $3.67 USD — it has decreased by -4.43% in the past 24 hours. Watch TAO Synergies stock price performance more closely on the chart.
What is TAO Synergies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange TAO Synergies stocks are traded under the ticker TAOX.
Is TAO Synergies stock price growing?▼
TAOX stock has risen by +1.38% compared to the previous week, the month change is a -20.22% fall, over the last year TAO Synergies has showed a -14.65% decrease.
What is TAO Synergies market cap?▼
Today TAO Synergies has the market capitalization of 26.16M
When is the next TAO Synergies earnings date?▼
TAO Synergies is going to release the next earnings report on August 07, 2026.
What were TAO Synergies earnings last quarter?▼
TAOX earnings for the last quarter are 0.43 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is TAO Synergies revenue for the last year?▼
TAO Synergies revenue for the last year amounts to 0 USD.
What is TAO Synergies net income for the last year?▼
TAOX net income for the last year is -27.12M USD.
How many employees does TAO Synergies have?▼
As of June 20, 2026, the company has 4 employees.
In which sector is TAO Synergies located?▼
TAO Synergies operates in the Technology sector.
When did TAO Synergies complete a stock split?▼
The last stock split for TAO Synergies was on April 05, 2024 with a ratio of 1:25.
Where is TAO Synergies headquartered?▼
TAO Synergies is headquartered in New York, United States.